Combination therapy of zonisamide with aripiprazole on ECT- and benzodiazepine-resistant periodic catatonia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 3, 2012, Pages

  Nakagawa, Masanori ^a   Yamamura, Satoshi ^a   Motomura, Eishi ^a   Shiroyama, Takashi ^a   Tanii, Hisashi ^a   Okada, Motohiro ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZONISAMIDE;

ADULT; CASE REPORT; CATATONIA; DISEASE SEVERITY; DRUG DOSE TITRATION; DSM-IV; ELECTROCONVULSIVE THERAPY; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; STUPOR; SYMPTOM;

EID: 84867539029     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11080191     Document Type: Letter

References (5)

1. Weder ND, Muralee S, Penland H, et al: Catatonia: a review. Ann Clin Psychiatry 2008; 20:97-107
2. Fink M, Taylor MA: The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 2001; 251(Suppl 1):I8-I13
3. Okada M, Kaneko S: Different mechanisms underlying the antiepileptic and antiparkinsonian effects of zonisamide, in Epilepsy. Edited by Foyaca-Sibat H. Rijeka, INTECH, 2011 in press.
4. Murata M, Hasegawa K, Kanazawa I; Japan Zonisamide on PD Study Group: Zonisamide improves motor function in Parkinson disease: a randomized, doubleblind study. Neurology 2007; 68:45-50
5. Newman-Tancredi A: The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives. Curr Opin Investig Drugs 2010; 11:802-812